Director Leslie Wims Morris of IQVIA Holdings Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 125 deferred shares on November 5, 2026, at a price of $264.88 per share under the company's Non-Employee Director Deferral Plan.

Key Highlights

  • Reporting person: Leslie Wims Morris, identified as a Director of IQVIA Holdings Inc. (NYSE:IQV)
  • Transaction date: November 5, 2026, with the filing submitted November 9, 2026
  • Securities acquired: 125 deferred shares at a price of $264.88 per share, coded as an acquisition (A)
  • Conversion terms: Each deferred share is convertible into one share of IQVIA Holdings Inc. common stock upon settlement
  • Post-transaction holdings: Morris holds 6,909 deferred shares directly following the reported transaction
  • Settlement triggers: Shares become settleable when the reporting person ceases to be a director, upon a change in control, or upon death; no expiry date applies

IQVIA Director Morris Adds to Deferred Share Holdings Under Non-Employee Plan

According to the filing, Leslie Wims Morris, a director of IQVIA Holdings Inc., acquired 125 deferred shares on November 5, 2026, at a stated price of $264.88 per share. IQVIA Holdings Inc. is a provider of data, technology, and research services to the life sciences industry, listed on the New York Stock Exchange under the ticker IQV. The transaction was reported under Table II, covering derivative securities, as deferred shares are classified as convertible instruments rather than outright common stock.

The filing discloses that the deferred shares were granted under IQVIA's Non-Employee Director Deferral Plan. Each deferred share converts on a one-for-one basis into common stock of IQVIA Holdings Inc. upon settlement. The filing specifies that settlement is triggered when the reporting person ceases to serve as a director, upon a change in control of the company, or upon the death of the reporting person. The filing further notes that there is no expiry date associated with these deferred shares.

Following the reported transaction, Morris beneficially owns 6,909 deferred shares on a direct basis, according to the filing. The form was signed by Abigail Jeck as Attorney-in-Fact for Leslie Wims Morris and dated November 9, 2026. No transactions were reported in Table I, which covers non-derivative securities.

What Was Disclosed

The filing reports a single acquisition of 125 deferred shares by IQVIA Holdings Inc. director Leslie Wims Morris on November 5, 2026, at $264.88 per share, bringing her total direct beneficial ownership of deferred shares to 6,909, with settlement contingent on specified future events.